HealthNews

WHO, Edo alerts over four drugs, warn against sales, usage

By Isaac Olamikan

Edo State Government has warned against the sale and usage of four medicines, noting that the drugs are being investigated by the World Health Organisation (WHO) for links with acute kidney injury and over 66 deaths among children in the Gambia.

In a statement, Edo State Commissioner for Health, Prof. Obehi Akoria, charged all pharmaceutical outlets who may have the medicines in stock to dispose of them forthwith, using the appropriate channels.

The drugs are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cough Syrup.

The Statement reads: “The World Health Organisation (WHO) has issued a global alert/warning over these four (4) medicines, including Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cough Syrup.

“These medicines are being investigated for links with acute kidney injury and over 66 deaths among children in the Gambia.

Read Also:

“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable quantities of diethylene glycol and ethylene glycol which are toxic to humans and may cause death.”

She further noted, “Officers of the National Agency for Food and Drug Administration and Control (NAFDAC) will provide an update shortly.

“All pharmaceutical outlets who may have these medicines in stock must dispose of them forthwith, using the appropriate channels.

The Commissioner added, “Please be vigilant! Do not use any of these drugs. No baby or toddler should be given cough or cold syrups.”

Follow The Trumpet on all our social media platforms for more updates:

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.